These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 17091236

  • 1. A high mobility group box-containing transcription factor leads to diabetes risk.
    Luft FC.
    J Mol Med (Berl); 2006 Dec; 84(12):985-7. PubMed ID: 17091236
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic variants and common diseases--better late than never.
    O'Rahilly S, Wareham NJ.
    N Engl J Med; 2006 Jul 20; 355(3):306-8. PubMed ID: 16855272
    [No Abstract] [Full Text] [Related]

  • 5. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function.
    Gloyn AL, Braun M, Rorsman P.
    Diabetes; 2009 Apr 20; 58(4):800-2. PubMed ID: 19336690
    [No Abstract] [Full Text] [Related]

  • 6. TCF7L2 and type 2 diabetes--we WNT to know.
    Smith U.
    Diabetologia; 2007 Jan 20; 50(1):5-7. PubMed ID: 17102948
    [No Abstract] [Full Text] [Related]

  • 7. TCF7L2: the biggest story in diabetes genetics since HLA?
    Zeggini E, McCarthy MI.
    Diabetologia; 2007 Jan 20; 50(1):1-4. PubMed ID: 17096114
    [No Abstract] [Full Text] [Related]

  • 8. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.
    Lehman DM, Hunt KJ, Leach RJ, Hamlington J, Arya R, Abboud HE, Duggirala R, Blangero J, Göring HH, Stern MP.
    Diabetes; 2007 Feb 20; 56(2):389-93. PubMed ID: 17259383
    [Abstract] [Full Text] [Related]

  • 9. Translating TCF7L2: from gene to function.
    Pearson ER.
    Diabetologia; 2009 Jul 20; 52(7):1227-30. PubMed ID: 19387612
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Open chromatin and diabetes risk.
    Groop L.
    Nat Genet; 2010 Mar 20; 42(3):190-2. PubMed ID: 20179731
    [No Abstract] [Full Text] [Related]

  • 12. Genetic architecture of type 2 diabetes: recent progress and clinical implications.
    Grant RW, Moore AF, Florez JC.
    Diabetes Care; 2009 Jun 20; 32(6):1107-14. PubMed ID: 19460916
    [No Abstract] [Full Text] [Related]

  • 13. Gene variant confers risk of diabetes.
    Hampton T.
    JAMA; 2006 Mar 01; 295(9):987-8. PubMed ID: 16507789
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
    Jin T, Liu L.
    Mol Endocrinol; 2008 Nov 01; 22(11):2383-92. PubMed ID: 18599616
    [Abstract] [Full Text] [Related]

  • 16. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S, Ostenson CG, Efendic S, Gu HF.
    Exp Clin Endocrinol Diabetes; 2009 Apr 01; 117(4):186-90. PubMed ID: 19053027
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.